Stay updated on HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial
Sign up to get notified when there's something new on the HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial page.

Latest updates to the HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added. The older Revision: v3.4.1 entry and the government funding notice were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedA site-wide notice about a lapse in government funding and the NIH Clinical Center status was added. The site version was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a Show glossary option and updated QC-related metadata to include 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. Previous items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed or renamed.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision tag updated to v3.3.4; prior tag v3.3.3 is no longer displayed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedLocations section updated to include Guangdong and Zhejiang as study sites. The HHS Vulnerability Disclosure link in the footer has been removed.SummaryDifference0.3%

- Check91 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2; no study details, eligibility criteria, locations, or contacts were affected.SummaryDifference0.1%

Stay in the know with updates to HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial page.